This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Institut Pasteur De Montevideo, University of the Republic, Other. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 8 
1 out of 11 
1 out of 834,453 Years Active: 2019-2021
Title: Unveiling the Innovative Mind of Lucia Colella
Introduction:
Lucia Colella, a pioneering inventor based in Montevideo, Uruguay, is making waves in the world of pharmaceuticals with her groundbreaking patents and innovative research. With a total of 2 patents under her name, Lucia Colella is revolutionizing the field of non-steroidal anti-inflammatory drugs (NA-NSAIDs) and methods of treating inflammation-related conditions.
Latest Patents:
One of Lucia Colella's latest patents is for Nitroalkene nonsteroidal anti-inflammatory drugs (NA-NSAIDs) and methods of treating inflammation-related conditions. This patent encompasses Nitroalkene non-steroidal anti-inflammatory compounds, pharmaceutical compositions thereof, and methods for effectively treating inflammation-related conditions.
Career Highlights:
Lucia Colella has contributed significantly to the field of pharmaceuticals through her work at prestigious institutions such as Institut Pasteur de Montevideo and Universidad de la República. Her dedication to innovation and research has led to the development of novel pharmaceutical compounds aimed at tackling inflammation-related conditions.
Collaborations:
Throughout her career, Lucia Colella has collaborated with notable professionals in the industry, including Carlos Batthyány and Gloria Virginia López. These collaborations have resulted in the exchange of ideas, expertise, and knowledge, further enhancing the impact of Lucia Colella's research and patents in the field of pharmaceuticals.
Conclusion:
In conclusion, Lucia Colella's innovative contributions to the field of pharmaceuticals, particularly in the development of Nitroalkene non-steroidal anti-inflammatory drugs and methods for treating inflammation-related conditions, underscore her commitment to advancing healthcare solutions. Her continued dedication to research and collaboration solidifies her position as a leading inventor in the realm of pharmaceutical innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile